Biotech for less than cash value Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech for less than cash value

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (307)	1/23/2008 10:58:30 PM
From: Jibacoa	Read Replies (1) of 684

O.T. I am still waiting for the results of the PI of IT-101, which are supposed to be ready any time.<g> clinicaltrials.gov According to the story by By Jerry Adler in the Nov 12, 2007 Issue of NEWSWEEK, at the time of the first trials, there was also a questionable pancreatic Ca. "cure". newsweek.com IT-101, went into the first phase of clinical trials, intended to establish a safe dosage. The problem was that it worked almost too well. His very first patient, a young man with pancreatic cancer who was given only about three months to live, is still alive today, more than a year later. Good results were also seen in patients with "massive" lung and kidney tumors. Of course, ARWR has also some interesting subsidiaries.<g> Message 24029818 Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next